Warfarin safe for AF, kidney disease: study

Swedish researchers found the anticoagulant was associated with a lower one-year risk of death and cardiovascular events without an increased risk of bleeding.

The findings are at odds with other reports that have questioned the value of anticoagulation in CKD.

Professor of stroke medicine and clinical neuroscience at the George Institute in Sydney, Craig Anderson, said that while the study was observational it was an important finding for clinical practice.

“The beneficial effects were pretty large in this group and it